Sagespring Wealth Partners, LLC Bristol Myers Squibb CO Transaction History
Sagespring Wealth Partners, LLC
- $4.64 Trillion
- Q2 2025
A detailed history of Sagespring Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sagespring Wealth Partners, LLC holds 14,159 shares of BMY stock, worth $653,437. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,159
Previous 21,578
34.38%
Holding current value
$653,437
Previous $1.32 Billion
50.2%
% of portfolio
0.01%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,675Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.32 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.99 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.37 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.27 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98.1B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...